X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10710) 10710
k562 cells (10080) 10080
science & technology (8213) 8213
life sciences & biomedicine (7408) 7408
animals (2783) 2783
biochemistry & molecular biology (2178) 2178
oncology (1929) 1929
apoptosis (1839) 1839
mice (1801) 1801
cell line, tumor (1736) 1736
leukemia (1632) 1632
apoptosis - drug effects (1596) 1596
antineoplastic agents - pharmacology (1537) 1537
cell biology (1435) 1435
hematology (1351) 1351
female (1234) 1234
pharmacology & pharmacy (1140) 1140
cell proliferation - drug effects (1093) 1093
flow cytometry (1040) 1040
male (1007) 1007
hl-60 cells (975) 975
cancer (970) 970
gene expression (966) 966
transfection (948) 948
immunology (929) 929
tumor cells, cultured (924) 924
cell line (922) 922
dose-response relationship, drug (887) 887
analysis (858) 858
proteins (836) 836
cell survival - drug effects (831) 831
research (809) 809
killer cells, natural - immunology (777) 777
hela cells (758) 758
cells, cultured (755) 755
molecular sequence data (718) 718
cytotoxicity (705) 705
k562 (702) 702
k562细胞 (702) 702
science & technology - other topics (701) 701
cell proliferation (679) 679
chemistry (675) 675
physical sciences (674) 674
base sequence (649) 649
protein binding (649) 649
abridged index medicus (644) 644
adult (601) 601
medicine, research & experimental (597) 597
research & experimental medicine (597) 597
rna, messenger - genetics (596) 596
leukemia, myelogenous, chronic, bcr-abl positive - pathology (591) 591
hemic and lymphatic diseases (586) 586
multidisciplinary sciences (576) 576
signal transduction (553) 553
reverse transcriptase polymerase chain reaction (550) 550
phosphorylation (542) 542
antineoplastic agents - chemistry (534) 534
jurkat cells (532) 532
chronic myeloid leukemia (531) 531
cell cycle (520) 520
time factors (517) 517
blotting, western (514) 514
drug screening assays, antitumor (514) 514
rna, messenger - metabolism (504) 504
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (499) 499
middle aged (490) 490
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (487) 487
molecular structure (486) 486
amino acid sequence (485) 485
cell differentiation - drug effects (482) 482
mutation (477) 477
leukemia, myelogenous, chronic, bcr-abl positive - genetics (473) 473
u937 cells (466) 466
drug resistance, neoplasm (465) 465
research article (463) 463
binding sites (461) 461
imatinib mesylate (461) 461
k562 cells - drug effects (458) 458
pyrimidines - pharmacology (446) 446
cell differentiation (444) 444
gene expression regulation (438) 438
structure-activity relationship (430) 430
genetics & heredity (424) 424
cells (421) 421
leukemia - pathology (415) 415
biophysics (409) 409
genetic aspects (406) 406
chemistry, medicinal (404) 404
genes (399) 399
piperazines - pharmacology (397) 397
promoter regions, genetic (393) 393
antineoplastic agents, phytogenic - pharmacology (382) 382
drug resistance, neoplasm - drug effects (375) 375
signal transduction - drug effects (369) 369
biology (359) 359
biotechnology & applied microbiology (357) 357
enzyme inhibitors - pharmacology (355) 355
benzamides (350) 350
fusion proteins, bcr-abl - genetics (349) 349
fusion proteins, bcr-abl - metabolism (349) 349
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11200) 11200
Chinese (2081) 2081
Japanese (92) 92
Russian (82) 82
Portuguese (25) 25
German (21) 21
Persian (18) 18
Korean (8) 8
Spanish (5) 5
Czech (4) 4
Norwegian (4) 4
Dutch (3) 3
Ukrainian (3) 3
French (2) 2
Italian (2) 2
Croatian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, pp. e30264 - e30264
NK cells have therapeutic potential for a wide variety of human malignancies. However, because NK cells expand poorly in vitro, have limited life spans in vivo... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell Proliferation | Artificial Cells - immunology | Coculture Techniques | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Gene Expression Profiling | Interleukin-15 - immunology | Interleukins - metabolism | Flow Cytometry | T-Lymphocytes - metabolism | U937 Cells | Interleukins - immunology | Receptors, KIR - metabolism | Killer Cells, Natural - immunology | Membrane Proteins - metabolism | Telomere - genetics | Cell Line | Antigen-Presenting Cells - metabolism | Immunotherapy, Adoptive - methods | Cells, Cultured | Immunophenotyping | Membrane Proteins - immunology | Antigen-Presenting Cells - immunology | Artificial Cells - metabolism | Interleukin-15 - metabolism | K562 Cells | Cell Line, Tumor | T-Lymphocytes - immunology | Killer Cells, Natural - metabolism | Receptors, KIR - immunology | Antigens | Fc receptors | Telomeres | Killer cells | Health aspects | Immunotherapy | Cell proliferation | Lymphocyte receptors | Cell culture | Pediatrics | Senescence | Transplants & implants | Transcription | Toxicity | Adoptive immunotherapy | Erythrocytes | Multiple myeloma | Science | Clinical trials | Cytotoxicity | Leukocytes | Cancer therapies | NKG2 antigen | Cell growth | Lymphocytes | Interleukin 21 | Killer cell immunoglobulin-like receptors | Biocompatibility | Natural killer cells | Expansion | Killing | Cytomegalovirus | Cytokines | Dendritic cells | Blood cells | T cell receptors | Tumor cell lines | Gene expression | Interleukin 15 | White blood cells | CD16 antigen | Biopsy | Antigen-presenting cells | Human performance | Ligands | Genetic engineering | Index Medicus
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, pp. e0148764 - e0148764
VTX-2337 (USAN: motolimod) is a selective toll-like receptor 8 (TLR8) agonist, which is in clinical development as an immunotherapy for multiple oncology indications, including squamous cell carcinoma of the head and neck (SCCHN... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | Leukocytes, Mononuclear - metabolism | Inflammasomes - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein | Humans | Macaca fascicularis | Caspase 1 - metabolism | Male | Receptors, IgG - metabolism | Carrier Proteins - agonists | Lymphocyte Activation - immunology | Neoplasms - genetics | Leukocytes, Mononuclear - immunology | Killer Cells, Natural - immunology | Female | Interleukin-1beta - biosynthesis | Disease Models, Animal | Toll-Like Receptor 8 - agonists | Leukocytes, Mononuclear - drug effects | Benzazepines - pharmacology | Cell Degranulation - immunology | Interleukin-18 - biosynthesis | Animals | Benzazepines - therapeutic use | Lymphocyte Activation - drug effects | Neoplasms - immunology | K562 Cells | Cell Line, Tumor | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Cytotoxicity, Immunologic - immunology | Cell Degranulation - drug effects | Physiological aspects | Toll-like receptors | Killer cells | Genetic aspects | Research | Immunotherapy | Toxicity | Cytotoxicity | Stimulation | Lymphocytes T | Monkeys | Cancer therapies | Caspase-1 | Metastases | NKG2 antigen | Cell activation | Epidermal growth factor | Lymphocytes | Rodents | Biocompatibility | Neck | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Squamous cell carcinoma | Cytokines | Dendritic cells | Tumor cells | Caspase | T cell receptors | Tumor necrosis factor-α | Patients | Interleukin 18 | Medicine | Monocytes | Complement activation | Pyrin protein | Womens health | γ-Interferon | Monoclonal antibodies | Ligands | Lymphomas | Pharmaceuticals | Index Medicus | Activation
Journal Article
PloS one, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, pp. e108925 - e108925
...) progression is poorly understood. In this study, we investigated the ability of prostate tumor-derived exosomes to downregulate NKG2D expression on natural killer (NK) and CD8(+) T cells... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Exosomes - metabolism | Cell Line | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | NK Cell Lectin-Like Receptor Subfamily K - chemistry | Antibodies, Monoclonal - pharmacology | Humans | Histocompatibility Antigens Class I - immunology | Intracellular Signaling Peptides and Proteins - immunology | Male | Intracellular Signaling Peptides and Proteins - metabolism | Down-Regulation - drug effects | Histocompatibility Antigens Class I - metabolism | Castration | NK Cell Lectin-Like Receptor Subfamily K - metabolism | Leukocytes, Mononuclear - immunology | Immune Evasion - drug effects | K562 Cells | CD8-Positive T-Lymphocytes - metabolism | Killer Cells, Natural - immunology | Leukocytes, Mononuclear - cytology | Killer Cells, Natural - metabolism | CD8-Positive T-Lymphocytes - immunology | Antibodies, Monoclonal - immunology | Plasma | Flow cytometry | Regulators | Toxicity | CD8 antigen | Cytotoxicity | Lymphocytes T | Exosomes | Cancer therapies | Proteins | Killer cells | Immunology | Lymphocytes | Rodents | Natural killer cells | Incubation | T cell receptors | Patients | Pathology | Cytometry | Surveillance | Pheochromocytoma cells | Ligands | Aberration | Prostate cancer | Prostate | Cancer | Apoptosis | Tumors | Index Medicus
Journal Article
Stem cells (Dayton, Ohio), ISSN 1066-5099, 04/2017, Volume 35, Issue 4, pp. 886 - 897
Journal Article
PloS one, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, pp. e0215678 - e0215678
Mesenchymal stem cells (MSCs) are of special interest due their potential clinical use in cell-based therapy... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cytokines - metabolism | Bone Marrow Cells - cytology | Coculture Techniques | Humans | Cells, Cultured | bcl-2-Associated X Protein - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Rats | Proto-Oncogene Proteins c-bcl-2 - metabolism | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Animals | Cell Cycle | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Mesenchymal Stem Cells - cytology | K562 Cells | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Chemokine CXCL1 - metabolism | Mesenchymal Stem Cells - metabolism | Proto-Oncogene Proteins c-bcl-2 - genetics | Bone Marrow Cells - metabolism | bcl-2-Associated X Protein - genetics | Apoptosis | Viral antibodies | Ethylenediaminetetraacetic acid | Care and treatment | Cytokines | Cell cycle | Stem cells | Antibodies | Diagnosis | Cancer | Research | Cell proliferation | Cell culture | Bax protein | Bcl-2 protein | Mesenchyme | Leukemia | Transplantation | Drug screening | Tissue inhibitor of metalloproteinase 1 | Caspase-3 | Proteins | Ethics | Bone marrow | Conditioning | Growth factors | G1 phase | Medical research | Hematology | Myeloid leukemia | Caspase | Chronic myeloid leukemia | Gene expression | Studies | Culture media | Umbilical cord | Index Medicus | Media (culture)
Journal Article
Experimental hematology, ISSN 0301-472X, 02/2013, Volume 41, Issue 2, pp. 155 - 166.e17
Journal Article